(Q46333921)

English

Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120.

scientific article published in December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

0 references

author name string

Cleland JL

1

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Barrón L

2

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Daugherty A

3

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Eastman D

4

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Kensil C

5

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Lim A

6

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Weissburg RP

7

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Wrin T

8

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Vennari J

9

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Powell MF

10

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

language of work or name

0 references

publication date

1 December 1996

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Journal of Pharmaceutical Sciences

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

85

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

12

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

1350-1357

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

The relative affinity of antibodies synthesized in the secondary response

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunizations: Current controversies

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired response to recombinant hepatitis B vaccine in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of Isotype Immunoglobulin Production by Adjuvants in Vivo

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of commercially available adjuvants for use in research

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-step immunization by sustained antigen release

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal Antibodies to the Extracellular Domain of HIV-1IIIB gp160 that Neutralize Infectivity, Block Binding to CD4, and React with Diverse Isolates

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of adjuvants on immunogenicity of MN recombinant glycoprotein 120 in guinea pigs

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dose and immunization schedule on immune response of baboons to recombinant glycoprotein 120 of HIV-1.

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis A vaccination: schedule for accelerated immunization

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

How many injections of poliomyelitis vaccine for effective and durable immunity

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinology of poliomyelitis

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration and efficacy of immune response to hepatitis B vaccine in high-risk Chinese adolescents

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

1 reference

https://api.crossref.org/works/10.1021%2FJS960329B

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1021/JS960329B

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 December 2017

http://europepmc.org/abstract/MED/8961152

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46333921&oldid=1447638452"